Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure

Clinical and Experimental Medicine

Volumn 12, Issue 3, 2012, Pages 159-164

  Chen, Tianyan ^a   He, Yingli ^a   Liu, Xiaojing ^a   Yan, Zhi ^a   Wang, Ke ^a   Liu, Hongli ^a   Zhang, Shuling ^a   Zhao, Yingren ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute on chronic liver failure; Enticavir; Hepatitis B virus; Lamivudine

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ENTECAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; TELBIVUDINE; VIRUS DNA;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ANTIVIRAL THERAPY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; SURVIVAL RATE; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GUANINE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84865470803     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0160-7     Document Type: Review

References (25)

1. RT Stravitz DJ Kramer 2009 Management of acute liver failure Nat Rev Gastroenterol Hepatol 6 542 553 19652652 10.1038/nrgastro.2009.127
2. SK Sarin A Kumar JA Almeida YK Chawla ST Fan H Garg HJ de Silva SS Hamid R Jalan P Komolmit GK Lau Q Liu K Madan R Mohamed Q Ning S Rahman A Rastogi SM Riordan P Sakhuja D Samuel S Shah BC Sharma P Sharma Y Takikawa BR Thapa CT Wai MF Yuen 2009 Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) Hep Int 3 269 282 10.1007/s12072-008-9106-x
3. [Anon], Liver EAS (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50:227-242
4. ASF Lok BJ McMahon 2009 Chronic hepatitis b: update 2009 Hepatology 50 661 662 19714720 10.1002/hep.23190
5. J Polson WM Lee 2005 AASLD position paper: the management of acute liver failure Hepatology 41 1179 1197 15841455 10.1002/hep.20703
6. YL Cui F Yan YB Wang XQ Song L Liu XZ Lei MH Zheng H Tang P Feng 2010 Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure Dig Dis Sci 55 2373 2380 20512414 10.1007/s10620-010-1257-7 1:CAS:528: DC%2BC3cXotVKlsb4%3D
7. J Chen JH Han C Liu RH Yu FZ Li QF Li GZ Gong 2009 Short-term entecavir therapy of chronic severe hepatitis B Hepatobiliary Pancreat Dis Int 8 261 266 19502165 1:CAS:528:DC%2BD1MXotlSjtLc%3D
8. SW Biggins WR Kim NA Terrault S Saab V Balan T Schiano J Benson T Therneau W Kremers R Wiesner P Kamath G Klintmalm 2006 Evidence-based incorporation of serum sodium concentration into MELD Gastroenterology 130 1652 1660 16697729 10.1053/j.gastro.2006.02.010
9. LJ Sun JW Yu YH Zhao P Kang SC Li 2010 Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure J Gastroenterol Hepatol 25 583 590 19968744 10.1111/j.1440-1746.2009. 06089.x 1:CAS:528:DC%2BC3cXlt1Shsr8%3D
10. CY Hsu HC Lin YH Huang CW Su FY Lee TI Huo PC Lee JY Lee SD Lee 2010 Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis Dig Liver Dis 42 137 142 19595648 10.1016/j.dld.2009.06.004 1:CAS:528:DC%2BC3cXpsFKrsrk%3D
11. VWS Wong GLH Wong KKL Yiu AML Chim SHT Chu HY Chan JJY Sung HLY Chan 2011 Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B J Hepatol 54 236 242 21030105 10.1016/j.jhep.2010.06.043 1:CAS:528:DC%2BC3MXmsVylug%3D%3D
12. Z Zhang ZS Zou JL Fu L Cai L Jin YJ Liu FS Wang 2008 Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure J Hepatol 49 396 406 18644645 10.1016/j.jhep.2008.05. 017 1:CAS:528:DC%2BD1cXpslSgtL4%3D
13. CD Williams ML Bajt A Farhood H Jaeschke 2010 Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice Liver Int 30 1280 1292 20500806 10.1111/j.1478-3231.2010.02284.x 1:CAS:528:DC%2BC3cXht1CltLnF
14. Manizate F, Fiel MI, Schwartz ME, Labow DM, Roayaie S, Dieterich D, Luan W, Hiotis SP (2010) Intrahepatic Cccdna burden and severity of hepatic fibrosis in patients with Hbv-associated Hcc. J Hepatol 52:S220
15. F Zoulim S Locarnini 2009 Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 137 1593 1608 19737565 10.1053/j.gastro.2009.08.063 1:CAS:528:DC%2BD1MXhsVyhsb%2FN
16. A Vallet-Pichard V Mallet CE Costentin S Pol 2009 Treatment of HBV-related cirrhosis Expert Rev Anti Infect Ther 7 527 535 19485793 10.1586/eri.09.28 1:CAS:528:DC%2BD1MXms1Kksbs%3D
17. AC Chan ST Fan CM Lo CL Liu SC Chan KK Ng BH Yong A Chiu BK Lam 2009 Liver transplantation for acute-on-chronic liver failure Hep Int 3 571 581 10.1007/s12072-009-9148-8
18. PC Chan HL Chen MS Kong FC Huang HC Lee CC Lin CC Liu IH Lee TC Wu SF Wu YH Ni HY Hsu MH Chang 2005 Factors affecting the mortality of pediatric fulminant hepatic failure in relation to hepatitis B virus infection J Gastroenterol Hepatol 20 1223 1227 16048570 10.1111/j.1440-1746.2005.03923.x
19. E Schiff H Simsek WM Lee YC Chao H Sette Jr HL Janssen SH Han Z Goodman J Yang H Brett-Smith R Tamez 2008 Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis Am J Gastroenterol 103 2776 2783 18721244 10.1111/j.1572-0241.2008.02086.x 1:CAS:528:DC%2BD1cXhsVOktL7N
20. MG Ghany EC Doo 2009 Antiviral resistance and hepatitis B therapy Hepatology 49 S174 S184 19399794 10.1002/hep.22900 1:CAS:528: DC%2BD1MXlvFKqsLc%3D
21. A Bartholomeusz S Locarnini 2006 Hepatitis B virus mutations associated with antiviral therapy J Med Virol 78 S52 S55 16622878 10.1002/jmv.20608 1:CAS:528:DC%2BD28Xnsl2ltbc%3D
22. E Doo TJ Liang 2001 Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection Gastroenterology 120 1000 1008 11231955 10.1053/gast.2001.22454 1:CAS:528:DC%2BD3MXitlertLg%3D
23. M Barile D Valenti S Passarella E Quagliariello 1997 3′-Azido- 3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator Biochem Pharmacol 53 913 920 9174103 10.1016/S0006-2952(96)00831-3 1:CAS:528:DyaK2sXjtVWku7c%3D
24. HLY Chan 2010 Antiviral therapy for acute-on-chronic liver failure in chronic hepatitis B: is it too late? Dig Dis Sci 55 2126 2128 20458619 10.1007/s10620-010-1266-6
25. A Katoonizadeh W Laleman C Verslype A Wilmer G Maleux T Roskams F Nevens 2010 Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study Gut 59 1561 1569 20675694 10.1136/gut.2009.189639